Wolfgang Woloszczuk
Overview
Explore the profile of Wolfgang Woloszczuk including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
296
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pena M, de Zeeuw D, Mischak H, Jankowski J, Oberbauer R, Woloszczuk W, et al.
Nephrol Dial Transplant
. 2015 Jul;
30 Suppl 4:iv86-95.
PMID: 26209743
Diabetic kidney disease occurs in ∼ 25-40% of patients with type 2 diabetes. Given the high risk of progressive renal function loss and end-stage renal disease, early identification of patients...
2.
Bieglmayer C, Dimai H, Gasser R, Kudlacek S, Obermayer-Pietsch B, Woloszczuk W, et al.
Wien Med Wochenschr
. 2012 Aug;
162(21-22):464-77.
PMID: 22890523
Aim: Reasonable application of laboratory parameters in prevention, diagnosis, treatment and therapy monitoring of osteoporosis. Target Groups: Physicians from different specialist disciplines (general medicine, geriatrics, gynaecology, urology, internal medicine-especially endocrinology...
3.
High cathepsin K levels in men with differentiated thyroid cancer on suppressive L-thyroxine therapy
Mikosch P, Kerschan-Schindl K, Woloszczuk W, Stettner H, Kudlacek S, Kresnik E, et al.
Thyroid
. 2008 Feb;
18(1):27-33.
PMID: 18302515
Background: Thyroid hormone administration is associated with low bone density in some studies. The aim of the present study was to evaluate the influence L-thyroxine, in doses used to treat...
4.
Hammerer-Lercher A, Puschendorf B, Sommer R, Mair J, Tulzer G, Lechner E, et al.
Clin Chim Acta
. 2008 Feb;
391(1-2):118-9.
PMID: 18280250
No abstract available.
5.
Skoumal M, Haberhauer G, Kolarz G, Hawa G, Woloszczuk W, Klingler A, et al.
Rheumatol Int
. 2007 Dec;
28(7):637-41.
PMID: 18075741
Osteoprotegerin (OPG) and soluble receptor activator of NF-kappa B ligand (sRANKL) together regulate the bone metabolism among other cytokines, whereby cathepsin K has a potent collagen-degrading activity. An imbalance of...
6.
Jarai R, Iordanova N, Jarai R, Jarai F, Raffetseder A, Woloszczuk W, et al.
Wien Klin Wochenschr
. 2007 Nov;
119(21-22):626-32.
PMID: 18043882
Background: N-terminal pro-brain natriuretic peptide (Nt-proBNP) is a strong independent predictor of death in acute coronary syndromes. In order to improve risk assessment in patients with unstable coronary artery disease...
7.
Hammerer-Lercher A, Puschendorf B, Sommer R, Mair J, Tews G, Shebl O, et al.
Clin Chim Acta
. 2006 Oct;
377(1-2):279-80.
PMID: 17069781
No abstract available.
8.
Zojer N, Brenner K, Beke D, Kudlacek S, Hawa G, Woloszczuk W, et al.
Anticancer Res
. 2005 Aug;
25(5):3607-12.
PMID: 16101188
Bisphosphonates are the standard treatment for hypercalcemia of malignancy. We hypothesized that bisphosphonate treatment and the subsequent fall in serum calcium might induce changes in the RANK/RANKL/OPG system, which plays...
9.
Ziegler S, Niessner A, Richter B, Wirth S, Billensteiner E, Woloszczuk W, et al.
Metabolism
. 2005 Jul;
54(7):935-8.
PMID: 15988704
Abstract The balance of the 2 cytokines, osteoprotegerin (OPG) and the receptor activator of nuclear factor kappa B ligand (soluble (s)RANKL), is known to have considerable influence on bone formation...
10.
Skoumal M, Haberhauer G, Kolarz G, Hawa G, Woloszczuk W, Klingler A
Arthritis Res Ther
. 2005 Jan;
7(1):R65-70.
PMID: 15642144
Cathepsin K is a cysteine protease that plays an essential role in osteoclast function and in the degradation of protein components of the bone matrix by cleaving proteins such as...